||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 581 active entries
401 West Morgan Road
Ann Arbor, 48108
United States of America, Michigan
Toll free: 855.383.7478
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Everist Genomics is driving growth by developing innovative prognostics with potential for substantive impact on medical and financial outcomes. Our strategy centers on proprietary research and development, targeted acquisitions, and in-licensing. Everist Genomics is currently developing a range of products aimed at improving treatment outcomes in Cancer and Cancer Supportive Care, Cardiovascular Disease, Metabolic Disease (e.g. diabetes) and Neurodegenerative Diseases (e.g. Alzheimer’s and Parkinson’s disease).
Last update of this entry: March 15, 2011